IL2RA and B-cell non-Hodgkin lymphoma: Many studies have shown that the serum level of soluble IL-2Rα, which is produced by CD4+ CD25+ T cells, is greater in B-cell NHL patients and is associated with a poorer prognosis [73, 87].